Genomic Surveillance Unit (Wellcome Sanger Institute)

Genomic Surveillance Unit (Wellcome Sanger Institute)

Public Health

We improve global human health by accelerating the use and impact of genomic surveillance.

About us

The Genomic Surveillance Unit (GSU) is a team at the Wellcome Sanger Institute dedicated to improving global human health by accelerating the use and impact of genomic surveillance. We deliver products, tools, and services that empower public health partners to add genomic information to their decision-making. The GSU brings expertise in genomics, data science, product development, and sequencing operations to bear on surveillance solutions for important human diseases. We currently focus on malaria, COVID-19, and a range of other respiratory viruses. Our world-leading COVID-19 and malaria genomic surveillance streams have a proven track record of successful implementation. We support partners around the world at every stage of the process, from sample collection and lab set-up to training, data generation, and analysis. The GSU’s priorities are to continually increase benefits to public health, while improving the accessibility and quality of genomic surveillance data. We seek to maximise the volume, quality, and scale of information that can be obtained from a sample and work to reduce the time to stand up functioning surveillance solutions. Driven by the needs of our partners, we create analytical tools, lab methods, and data pipelines that push the boundaries of what’s possible.

Website
https://www.sanger.ac.uk/collaboration/genomic-surveillance-unit/
Industry
Public Health
Company size
51-200 employees
Headquarters
Hinxton
Type
Nonprofit
Founded
2022
Specialties
genomics, science, big data, public health, research, product development, cloud computing, biology, malaria, covid-19, and mosquito

Locations

Employees at Genomic Surveillance Unit (Wellcome Sanger Institute)

Updates

Affiliated pages

Similar pages